Pharmacist's Letter | CE & Recommendations You Can Trust

Current Issue

December 2024 Issue

Prepare to Give More Adults a Pneumococcal Vaccine

We’re getting lots of questions about pneumococcal vaccines for adults...

Resources

Chart: Comparison of Pneumococcal Vaccines
Algorithm: Pneumococcal Vaccination in Adults

Educate About the Medicare Prescription Payment Plan

Questions are swirling about the new Medicare Prescription Payment Plan (MPPP)...

Tackle Ongoing GLP-1 Agonist Questions

Questions continue to pour in about GLP-1 agonists (semaglutide, etc)...

Don’t Rush to Aprocitentan for Resistant Hypertension

Aprocitentan (Tryvio) will be the first dual endothelin antagonist approved for resistant hypertension...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Influenza Immunization in Special Populations

CE IN THE LETTER: Pharmacist's Letter November 2024

LIVE CE: Pharmacy Essential Updates November 2024

PODCAST CE: Medication Talk - Immunization Updates 2024

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GO TO ALL CLINICAL RESOURCES >

What is Pharmacist’s Letter?

Pharmacist's Letter is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Free CE for Pharmacists

Pharmacist's Letter offers ACPE-accredited CE at no charge to help pharmacists meet license renewal requirements. Claim your free CE now:

Group Purchases & Pricing

Pharmacist’s Letter is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information